Author:
Burhan Erlina,Ruesen Carolien,Ruslami Rovina,Ginanjar Arum,Mangunnegoro Hadiarto,Ascobat Purwantyastuti,Donders Rogier,van Crevel Reinout,Aarnoutse Rob
Abstract
ABSTRACTNumerous studies have reported low concentrations of antituberculosis drugs in tuberculosis (TB) patients, but few studies have examined whether low drug concentrations affect TB treatment response. We examined steady-state plasma concentrations of isoniazid, rifampin, and pyrazinamide at 2 h after the administration of drugs (C2 h) among 181 patients with pulmonary tuberculosis in Indonesia and related these to bacteriological response during treatment.C2 hvalues below reference values for either isoniazid, rifampin, or pyrazinamide were found in 91% of patients; 60% had at least two lowC2 hconcentrations. The isoniazidC2 hwas noticeably lower in fast versus slow acetylators (0.9 mg/liter versus 2.2 mg/liter,P< 0.001). At the end of treatment, 82% of the patients were cured, whereas 30 patients (17%) had dropped out during the study, and 2 patients (1%) failed treatment. No association was found betweenC2 hconcentrations and sputum culture results at 8 weeks of treatment.Post hocanalysis showed that patients with low pyrazinamideC2 h(P= 0.01) and patients with large extensive lung lesions (P= 0.01) were at risk of at least one positive culture at week 4, 8, or 24/32. Antituberculosis drug concentrations were often low, but treatment response was nevertheless good. No association was found between drug concentrations and 8 weeks culture conversion, but low pyrazinamide drug concentrations may be associated with a less favorable bacteriological response. The use of higher doses of pyrazinamide may warrant further investigation.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Cited by
85 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献